Once the patient has reached their goal weight, oral semaglutide dosage may change as the patient transitions from active weight loss to weight management
On average, semaglutide led to a placebo-corrected weight loss of about 12%, while tirzepatide reached an impressive 18% reduction in body weight
The glucose consumption of the brain and its dependence on the liver
JACC 84(1):2740 Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Others didn't truly stop obesity treatment at all: More than one-quarter switched to a different weight loss medication, and nearly one in five restarted their original GLP-1 within about six months
The researchers then used mouse experiments to test the relationship between T2DM, COVID-19 infection and pulmonary fibrosis